drugset / Trial / NCT03639766
The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aims to investigate the effect of abobotulinum toxin A on the symptoms of Raynaud's phenomenon.
Timeline
- Start
- 2018-08-31
- Primary completion
- 2020-01-31
- Completion
- 2020-01-31
Outcome
Outcome not reported
Stopped: “Time and resource constraints”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 300 iu | Other |